Authors: J. Slipac Authors‘ workplace: Předseda: doc. MUDr. Ivan Čundrle, CSc. ; Česká společnost bezkrevní medicíny, Brno Published in: Prakt. Lék. 2010; 90(5): 286-290 Category: Various Specialization
During last decades, important progress has been made in the treatment of bleeding utilizing hemostatic agents, procedures and techniques. Local and general hemostatics are used in general open and laparoscopic surgery. The article briefly describes mechanisms of blood coagulation and possibilities of treatment of bleeding resulting from surgical operations.
Key words: hemostasis, general hemostatics, local hemostatics.
1. Chen, R.H., Frazier, O.H., Cooley, D.A. Antifibrinolytic therapy in cardiac surgery. Tex. Heart Inst. J. 1995, 22(3), p. 211–215.
2. Czinn, E.A., Chediak, J.R. Coagulation and hemostasis. In: Salem MR, editor. Blood Conservation in the Surgical Patient. Baltimore: Williams & Wilkins 1996, p. 45–78.
3. Douglas, J.T., Shaw, J. High-dose desmopressin in bleeding disorders. Eur. J. Anaesthesiol. 1997, 14, (Suppl 14), p. v–vi.
4. Haber, G.P., Gill, I.S. Laparoscopic partial nephrectomy: contemporary technique and outcomes. Eur. Urol. 2006, 49, p. 660–665.
5. Hedner, U., Ezban, M. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis. Annu. Rev. Med. 2008, 59, p. 29–41.
6. Hedner, U. Recombinant factor VIIa: its background, development and clinical use. Curr. Opin. Hematol. 2007, 14(3), p. 225–229.
7. Hedner, U. Mechanism of action, development and clinical experience of recombinant FVIIa. J. Biotechnol. 2006, 124(4), p. 747–757.
8. Holcomb, J.B., Pusateri, A.E., Hess, J.R. et al. Implications of new dry fibrin sealant technology for trauma surgery. Surg. Clin. North. Am. 1997, 77(4), p. 943–952.
9. Kasirajan, K., Cornu-Labat, G., Mehta, T. et al. Intracavitary packing with oxidized regenerated cellulose: a therapeutic option following major liver injury. Contemp. Surg. 1998, 52, p. 123-127.
10. Mair, H., Kaczmarek, I., Oberhoffer, M. et al. Surgicel Nu-Knit hemostat for bleeding control of fragile sternum. J. Thorac. Cardiovasc. Surg. 2005, 130, p. 605-606.
11. Ragusa, R., Faggian, G., Rungatscher, A. et al. Use of gelatin powder added to rifamycin versus bone wax in sternal wound hemostasis after cardiac surgery. Interact. CardioVasc. Thorac. Surg. 2007, 6, p. 52-55.
12. Sabel, M., Stummer, W. The use of local agents: Surgicel and Surgifoam. Eur. Spine. J. 2004, 13 (Suppl. 1), S97-S101.
13. Seto, A.H., Dunlap, D.S. Tranexemic acid in oncology. Ann. Pharmacother. Surg. 1996, 30(7–8), p. 868–870.
14. Sharma, J.B., Malhotra, M., Pundir, P. Laparoscopic oxidized cellulose (Surgicel) application for small uterine perforations. Int. J. Gynaecol. Obstet. 2003, 83, p. 271-275.
15. Slipac, J. Bezkrevní medicína. Praha: Triton 2008.
16. Spangler, D., Rothenburger, S., Nguyen, K. et al. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic - resistant microorganisms. Surg. Infect. 2003, 4(3), p. 255-262.
17. Trooskin, S.Z., Flancbaum, L., Boyarsky, A.H., Greco, R.S. A simplified approach to techniques of splenic salvage. Surg. Gynecol. Obstet. 1989, 168, p. 546-548.
18. White, B., McHale, J., Ravi, N. et al. Successful use of recombinant FVIIa (NovoSeven®) in the management of intractable post-surgical intra-abdominal haemorrhage. Br. J. Haematol. 1999, 107, p. 677–678.
19. White, G.C., Marder, V.J., Colman, R.W. et al. Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, George JN, Goldhaber SZ (eds.). Hemostasis and Thrombosis. Basic principles and clinical practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins 1994; p. 1134–1147.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
